This inventor holds 6 USPTO granted patents and 15 published patent applications and 2 EPO patents. Top assignees: Medshine Discovery Inc., Shijiazhuang Sagacity New Drug Development Company, Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations and Contributions of Inventor Yu Xu
Introduction
Yu Xu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors related to various diseases. With a total of four patents to his name, his work reflects a commitment to advancing medical science.
Latest Patents
Yu Xu's latest patents include a bicyclic compound that acts as a CRBN protein regulator. This compound is represented by a specific formula and is intended for use in preparing medications for treating diseases associated with the CRBN receptor. Another significant patent involves a crystal form of the 1H-imidazo[4,5-b]pyridine-2(3H)-one compound, along with its preparation process. This crystal form is utilized in the manufacture of medicaments aimed at treating diseases linked to the PDE4 receptor.
Career Highlights
Throughout his career, Yu Xu has worked with several prominent companies, including Medshine Discovery Inc. and Shijiazhuang Sagacity New Drug Development Company, Ltd. His experience in these organizations has allowed him to contribute to various innovative projects and research initiatives.
Collaborations
Yu Xu has collaborated with notable colleagues, including Yunfu Luo and Maoyi Lei. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.
Conclusion
In summary, Yu Xu's innovative work and patents demonstrate his significant impact on the pharmaceutical industry. His contributions continue to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile